TREE NEWS update: Moderna’s stock surged 30% in pre-market trading, marking a significant move for the biotech company. The sharp rise suggests strong investor sentiment, possibly driven by recent news or developments. This rally highlights the volatility and momentum in the pharmaceutical sector.
Moderna’s Pre-Market Gains Expand to 30%
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
2h ago
Chinese Brokers Hold $7.6B in 239 Stocks as Top-10 Shareholders
3h ago
Changxin Technology Completes Engineering Sample Validation for 4F²-Based Sixth-Gen DRAM Platform
6h ago
China Reform and Chengtong Add A-Share Stakes in Power, Energy, Semiconductors
6h ago
CITIC Securities: Bank Stocks Set for Repricing from High-Dividend Defensive Assets
8h ago
Intel’s weak Q4 guidance and AI capex fears sink tech stocks; Nasdaq falls over 5% in October
8h ago
Anthropic S-1 Filing Lifts Vertiv 25%, Nvidia Just 2.1% in Three Sessions